Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment

Background. We examined (1) patient characteristics and disease-modifying drug (DMD) exposure in late-onset (LOMS, ≥50 years at symptom onset) versus adult-onset (AOMS, 18–<50 years) MS and (2) the association between interferon-beta (IFNβ) and disability progression in older relapsing-onset MS a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirani, Afsaneh, Zhao, Yinshan, Petkau, John, Gustafson, Paul, Karim, Mohammad Ehsanul, Evans, Charity, Kingwell, Elaine, van der Kop, Mia L., Oger, Joel, Tremlett, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397470/
https://www.ncbi.nlm.nih.gov/pubmed/25922836
http://dx.doi.org/10.1155/2015/451912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397470/
https://www.ncbi.nlm.nih.gov/pubmed/25922836
http://dx.doi.org/10.1155/2015/451912

Ejemplares similares